Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study Using Placenta Derived Decidual Stromal Cells for Toxicity and Inflammation With Special Focus to the Allogeneic Hematopoietic Cell Transplantation Setting

NCT02175303 is registered in ClinicalTrials.gov with Karolinska Institutet as lead sponsor.

NCT NCT02175303
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02175303 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study Using Placenta Derived Decidual Stromal Cells for Toxicity and Inflammation With Special Focus to the Allogeneic Hematopoietic Cell Transplantation Setting
Lead sponsor
Karolinska Institutet
Phase
Phase 1/2
Overall status
Unknown status
Start date
December 31, 2013
Completion date
December 31, 2017
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute lung injury, decidual stromal cells, inflammation, stem cell transplantation